.Welcome to this week's Chutes & Ladders, our summary of substantial leadership hirings, firings ...
.Following a bad revealing for Lykos Therapeutics' MDMA candidate for trauma at a current FDA adviso...
.AN2 Rehabs is actually re-thinking its organization in reaction to lackluster midphase records, swe...
.Merck & Co. is actually paying out $700 million upfront to test Amgen in a blood cancer cells ma...
.Along With Gilead Sciences on the verge of an FDA choice for its own liver ailment drug seladelpar,...
.CEO David Ricks can easily find the companies establishing camping tents at basecamp responsible fo...
.Bed Liquidators has actually transformed Entero Therapies white as a sheet. The creditor purchased ...
.Exelixis is losing hope on its cells variable (TF)- targeting antibody-drug conjugate after wrappin...
.3 weeks after Roche's Genentech device left an SHP2 inhibitor pact, Relay Therapy has actually conf...
.Stoke Rehabs' Dravet syndrome medication has been actually freed from a predisposed hold, removing ...